GT201300211A - Síntesis de derivados de 2-carboxamida-cicloamino-urea - Google Patents

Síntesis de derivados de 2-carboxamida-cicloamino-urea

Info

Publication number
GT201300211A
GT201300211A GT201300211A GT201300211A GT201300211A GT 201300211 A GT201300211 A GT 201300211A GT 201300211 A GT201300211 A GT 201300211A GT 201300211 A GT201300211 A GT 201300211A GT 201300211 A GT201300211 A GT 201300211A
Authority
GT
Guatemala
Prior art keywords
cicloamino
carboxamida
urea
synthesis
derivatives
Prior art date
Application number
GT201300211A
Other languages
English (en)
Spanish (es)
Inventor
Erb Bernhard
Gallou Isabelle Sylvie
Kleinbeck Florian Karl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201300211(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201300211A publication Critical patent/GT201300211A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GT201300211A 2011-03-03 2013-08-28 Síntesis de derivados de 2-carboxamida-cicloamino-urea GT201300211A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03

Publications (1)

Publication Number Publication Date
GT201300211A true GT201300211A (es) 2014-12-30

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201300211A GT201300211A (es) 2011-03-03 2013-08-28 Síntesis de derivados de 2-carboxamida-cicloamino-urea

Country Status (33)

Country Link
US (3) US9650373B2 (enExample)
EP (1) EP2681192B1 (enExample)
JP (1) JP6022485B2 (enExample)
KR (1) KR101851421B1 (enExample)
CN (2) CN106083840B (enExample)
AR (2) AR088714A1 (enExample)
AU (1) AU2012222346B2 (enExample)
BR (1) BR112013021882A2 (enExample)
CA (1) CA2828509C (enExample)
CL (1) CL2013002521A1 (enExample)
CO (1) CO6751286A2 (enExample)
DK (1) DK2681192T3 (enExample)
EA (4) EA025381B1 (enExample)
EC (1) ECSP13012914A (enExample)
ES (1) ES2663717T3 (enExample)
GT (1) GT201300211A (enExample)
HU (1) HUE036319T2 (enExample)
IL (1) IL228023A (enExample)
MA (1) MA34982B1 (enExample)
MX (2) MX351740B (enExample)
MY (1) MY163214A (enExample)
NO (1) NO2681192T3 (enExample)
PE (1) PE20140917A1 (enExample)
PH (1) PH12013501796A1 (enExample)
PL (1) PL2681192T3 (enExample)
PT (1) PT2681192T (enExample)
SG (1) SG192793A1 (enExample)
SI (1) SI2681192T1 (enExample)
TN (1) TN2013000354A1 (enExample)
TW (2) TWI597279B (enExample)
UA (1) UA112539C2 (enExample)
WO (1) WO2012117071A1 (enExample)
ZA (1) ZA201306174B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
EP3218349A2 (en) * 2014-11-14 2017-09-20 Gemphire Therapeutics Inc. Processes and intermediates for preparing , -dicarboxylic acid-terminated dialkane ethers
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
MXPA02002559A (es) 1999-09-10 2002-07-30 Merck & Co Inc Inhibidores de tirosina cinasa.
AR044519A1 (es) * 2003-05-02 2005-09-14 Novartis Ag Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
JP2009524677A (ja) * 2006-01-25 2009-07-02 シンタ ファーマシューティカルズ コーポレーション 炎症および免疫関連使用用のチアゾールおよびチアジアゾール化合物
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
JP2011506560A (ja) * 2007-12-20 2011-03-03 ノバルティス アーゲー Pi3キナーゼ阻害剤として用いられるチアゾール誘導体
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
US9776966B2 (en) 2017-10-03
US9650373B2 (en) 2017-05-16
KR101851421B1 (ko) 2018-04-23
US20170240509A1 (en) 2017-08-24
KR20140009432A (ko) 2014-01-22
PT2681192T (pt) 2018-04-02
EP2681192A1 (en) 2014-01-08
EA025381B1 (ru) 2016-12-30
PL2681192T3 (pl) 2018-06-29
SG192793A1 (en) 2013-09-30
CL2013002521A1 (es) 2014-02-14
CN103402982B (zh) 2016-07-13
AU2012222346A1 (en) 2013-08-29
CA2828509C (en) 2018-11-20
IL228023A (en) 2017-04-30
ES2663717T3 (es) 2018-04-16
ZA201306174B (en) 2014-05-28
CN106083840B (zh) 2020-01-03
CN106083840A (zh) 2016-11-09
TW201247660A (en) 2012-12-01
EP2681192B1 (en) 2017-12-27
MA34982B1 (fr) 2014-03-01
MX351740B (es) 2017-10-26
EA201892052A1 (ru) 2019-02-28
US10059670B2 (en) 2018-08-28
JP2014511387A (ja) 2014-05-15
SI2681192T1 (en) 2018-04-30
NZ614173A (en) 2015-04-24
US20170355677A1 (en) 2017-12-14
NO2681192T3 (enExample) 2018-05-26
CO6751286A2 (es) 2013-09-16
UA112539C2 (uk) 2016-09-26
MX2013010132A (es) 2013-10-30
TW201722916A (zh) 2017-07-01
AR123584A2 (es) 2022-12-21
JP6022485B2 (ja) 2016-11-09
TWI607994B (zh) 2017-12-11
ECSP13012914A (es) 2013-11-29
CA2828509A1 (en) 2012-09-07
DK2681192T3 (en) 2018-04-16
TN2013000354A1 (en) 2015-01-20
MX347348B (es) 2017-04-17
MY163214A (en) 2017-08-30
AR088714A1 (es) 2014-07-02
BR112013021882A2 (pt) 2016-07-19
TWI597279B (zh) 2017-09-01
EA201792068A3 (ru) 2018-05-31
PE20140917A1 (es) 2014-08-14
EA201391267A1 (ru) 2014-01-30
HUE036319T2 (hu) 2018-06-28
EA032802B1 (ru) 2019-07-31
EA201792068A2 (ru) 2018-01-31
WO2012117071A1 (en) 2012-09-07
US20130331579A1 (en) 2013-12-12
IL228023A0 (en) 2013-09-30
PH12013501796A1 (en) 2022-10-26
AU2012222346B2 (en) 2015-05-07
CN103402982A (zh) 2013-11-20
EA201691331A1 (ru) 2017-01-30

Similar Documents

Publication Publication Date Title
CR20140042A (es) Indazoles
CR20130470A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA
MX338078B (es) Cristales de anticuerpos anti-esclerostina y formulaciones de los mismos.
BR112013031713A2 (pt) núcleo absorvente para artigos absorventes descartáveis
CU24354B1 (es) Procedimiento de obtención de derivados de tetrafluoropropilmorfolina
MX2015013042A (es) Compuestos organicos.
PT2693881T (pt) Análogos de n-fenilpirimidin-2-amina substituídos como inibidores da axl cinase
UY33353A (es) Compuestos adecuados para el tratamiento de trastornos metabolicos y metodos de preparacion
PT2720562T (pt) Resumo
PL2760821T3 (pl) Sól cholinowa przeciwzapalnego związku podstawionego cyklobutenodionem
CR20140554A (es) Compuestos de acido dimetil-benzoico
IL232380A0 (en) Compounds for the modulation of connection 2 smn
IL229205A0 (en) A useful preparation for the treatment of lipid metabolism disorders
MX2016008841A (es) Moduladores heterociclicos de la sintesis de lipidos para su uso contra el cancer e infecciones virales.
GT201400242A (es) "nuevos compuestos de pirazol"
BR112013030370A2 (pt) compostos de quinona para tratamento de doenças mediadas por ape1
CO6751286A2 (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
ES2636441T8 (es) Un procedimiento novedoso para la síntesis de polifenoles
CR20150006A (es) Metodo para preparar triazolopiridinas sustituidas
CO6801745A2 (es) Composición que comprende diaminooxidasa para la prevención de los sintomas de la resaca
AR098879A1 (es) Síntesis de ent-progesterona y sus productos intermedios
MY158088A (en) Stable lipid emulsion containing prostaglandin e1
CU24311B1 (es) Método de preparación de compuestos alfa-galactosil ceramidas
PA8728901A1 (es) Metodos para preparar derivados de acido glutamico e intermediarios del mismo
ZA201309224B (en) Process for the synthesis of diclofenac choline salt